BackgroundThe chronic kidney disease (CKD) is a worldwide critical problem, especially in developing countries. CKD patients usually begin their treatment in advanced stages, which requires dialysis and kidney transplantation, and consequently, affects mortality rates. This issue is faced by a mobile health (mHealth) application (app) that aims to assist the early diagnosis and self-monitoring of the disease progression.MethodsA user-centered design (UCD) approach involving health professionals (nurse and nephrologists) and target users guided the development process of the app between 2012 and 2016. In-depth interviews and prototyping were conducted along with healthcare professionals throughout the requirements elicitation process. Elicited requirements were translated into a native mHealth app targeting the Android platform. Afterward, the Cohen’s Kappa coefficient statistics was applied to evaluate the agreement between the app and three nephrologists who analyzed test results collected from 60 medical records. Finally, eight users tested the app and were interviewed about usability and user perceptions.ResultsA mHealth app was designed to assist the CKD early diagnosis and self-monitoring considering quality attributes such as safety, effectiveness, and usability. A global Kappa value of 0.7119 showed a substantial degree of agreement between the app and three nephrologists. Results of face-to-face interviews with target users indicated a good user satisfaction. However, the task of CKD self-monitoring proved difficult because most of the users did not fully understand the meaning of specific biomarkers (e.g., creatinine).ConclusionThe UCD approach provided mechanisms to develop the app based on the real needs of users. Even with no perfect Kappa degree of agreement, results are satisfactory because it aims to refer patients to nephrologists in early stages, where they may confirm the CKD diagnosis.
The high incidence and prevalence of chronic kidney disease (CKD), often caused by late diagnoses, is a critical public health problem, especially in developing countries such as Brazil. CKD treatment therapies, such as dialysis and kidney transplantation, increase the morbidity and mortality rates, besides the public health costs. This study analyses the usage of machine learning techniques to assist in the early diagnosis of CKD in developing countries. Qualitative and quantitative comparative analyses are, respectively, conducted using a systematic literature review and an experiment with machine learning techniques, with the k-fold cross-validation method based on the Weka software and a CKD dataset. These analyses enable a discussion on the suitability of machine learning techniques for screening for CKD risk, focusing on low-income and hard-to-reach settings of developing countries, due to the specific problems faced by them, e.g., inadequate primary health care. The study results show that the J48 decision tree is a suitable machine learning technique for such screening in developing countries, due to the easy interpretation of its classification results, with 95.00% accuracy, reaching a nearly perfect agreement with an experienced nephrologist's opinion. Conversely, random forest, naive Bayes, support vector machine, multilayer perceptron, and k-nearest neighbor techniques, respectively, yield 93.33%, 88.33%, 76.66%, 75.00%, and 71.67% accuracy, presenting at least moderate agreement with the nephrologist, at the cost of a more difficult interpretation of the classification results. INDEX TERMS Reviews, machine learning, medical diagnosis.
Background Controlling the COVID-19 outbreak in Brazil is a challenge due to the population’s size and urban density, inefficient maintenance of social distancing and testing strategies, and limited availability of testing resources. Objective The purpose of this study is to effectively prioritize patients who are symptomatic for testing to assist early COVID-19 detection in Brazil, addressing problems related to inefficient testing and control strategies. Methods Raw data from 55,676 Brazilians were preprocessed, and the chi-square test was used to confirm the relevance of the following features: gender, health professional, fever, sore throat, dyspnea, olfactory disorders, cough, coryza, taste disorders, and headache. Classification models were implemented relying on preprocessed data sets; supervised learning; and the algorithms multilayer perceptron (MLP), gradient boosting machine (GBM), decision tree (DT), random forest (RF), extreme gradient boosting (XGBoost), k-nearest neighbors (KNN), support vector machine (SVM), and logistic regression (LR). The models’ performances were analyzed using 10-fold cross-validation, classification metrics, and the Friedman and Nemenyi statistical tests. The permutation feature importance method was applied for ranking the features used by the classification models with the highest performances. Results Gender, fever, and dyspnea were among the highest-ranked features used by the classification models. The comparative analysis presents MLP, GBM, DT, RF, XGBoost, and SVM as the highest performance models with similar results. KNN and LR were outperformed by the other algorithms. Applying the easy interpretability as an additional comparison criterion, the DT was considered the most suitable model. Conclusions The DT classification model can effectively (with a mean accuracy≥89.12%) assist COVID-19 test prioritization in Brazil. The model can be applied to recommend the prioritizing of a patient who is symptomatic for COVID-19 testing.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.